Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Cell growth regulating factor II and its prepn process

A cell growth regulatory factor and gene technology, applied in the field of biomedicine, can solve problems such as abnormal repair, lack of therapeutic effect, necrosis of human cells and tissues, etc., and achieve the effect of TC enhancement and anti-aging

Inactive Publication Date: 2004-06-23
谢旭明
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are no documents with similar "longevity medicine" published.
On the other hand, even if a person has not entered old age, there will still be necrosis of human cells and tissues in some parts of his body, which cannot be repaired normally, such as patients with cervical spondylosis or patients with lumbar disc herniation, etc.
Most of these patients are elderly, and the pathogenesis is mainly due to the existence of degeneration, atrophy, necrosis and fibrosis in some parts of the human body. The conventional treatment method is surgical resection, and then replanting the tissue or transplanting the corresponding tissue. This surgical treatment method is only passive and does not have a positive therapeutic effect. It can only perform destructive treatment, and its effect is not ideal at all.
There is also a treatment that uses collagenase, hyaluronidase or collagen, but collagenase, hyaluronidase and collagen only dissolve necrotic fibrotic tissue, but do not regenerate and repair cellular tissue and remodeling, etc., therefore, they do not actually have a good therapeutic effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0015] Example 2, Gram-negative cocci were first screened and the strains were frozen and preserved, and the strains were routinely cultured at a temperature of 9°C. After the strains were fully cultured, they were filtered three times successively to remove impurities and harmful bacteria, leaving beneficial bacteria fragments , which is to extract the natural gene; take 1 μg of the natural gene, add 3mg of tyrosine quantitatively to it, measure the content and pass the safety test, and seal it under the GMP standard to form the natural cell growth regulatory factor H. After the finished product passes the inspection, Printed packaging.

Embodiment 3

[0016] Example 3, the Gram-negative bacilli were first screened and the strains were frozen and preserved, and the strains were conventionally cultured at a temperature of 20°C. After the strains were fully cultivated, they were filtered twice successively to remove impurities and harmful bacteria, leaving beneficial bacteria Fragments are the extraction of natural genes; take 1 μg of natural genes, add 8 mg of tyrosine quantitatively to it, measure the content and pass the safety test, and seal the natural cell growth regulatory factor H under the GMP standard. , Printing packaging.

Embodiment 4

[0017] Example 4, the Gram-positive bacilli were first screened and the strains were frozen and stored, and the strains were conventionally cultured at a temperature of 38°C. After the strains were fully cultivated, they were filtered once to remove impurities and harmful bacteria, leaving beneficial bacteria fragments. That is to extract natural genes, usually the more times of filtering, the purer the filter materials such as the remaining (extracted) beneficial bacteria fragments, that is, the natural genes. Take 1 μg of natural gene, add 20mg of tyrosine to it quantitatively, measure the content and pass the safety test, and seal it under the GMP standard to form the natural cell growth regulator factor H. After the finished product passes the inspection, it will be printed and packaged.

[0018] Other embodiments of the present invention can be freely configured within the range of 1 μg of gene and 1 μg to 500 mg of tyrosine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is one kind of natural cell growth regulating factor H and its preparation process. The preparation process includes screening Gram-positive coccus or bacillus and Gram-negative coccus or bacillus, freeze preserving coccus or bacillus strain, conventional culture of the coccus or bacillus strain at 4-38 deg.c, once filtering to eliminate harmful bacteria while leaving beneficial thallus segment, extracting natural gene, adding tyrosine into the natural gene, safety test, preparing into solution or powder, and sealing. The cell growth regulating factor H has the functions of stimulating and strengthening immunity, strengthening TC, repairing and reforming necrotic, degenerative, atrophic, fibrillated and calcified pancreatic histiocyte, regenerating capillary vessel, so that it can rejuvenate prostate and delay senility.

Description

technical field [0001] The invention relates to a medicine beneficial to the growth regulation of biological cells and a preparation method thereof, belonging to a kind of biological medicine. Background technique [0002] Birth, old age, sickness and death are a natural law for human beings. With the aging of human cells, the regenerative function of the cells will gradually lose. The human body enters the aging period, and various cells in the human body decline. For example, the recovery of the elderly is much slower than that of the young. A lot is a good proof. Human aging is mainly manifested in cell aging and functional decline of various internal organs. Therefore, in recent years, medical experts from all over the world are trying to study "longevity medicine" to prolong human life. The so-called longevity medicine is nothing more than that this kind of medicine can promote the regeneration of human cells and the enhancement and improvement of repair ability. Howe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7088A61K35/74A61P13/08A61P37/04
Inventor 谢旭明谢黎升黎景黎智谢昱青
Owner 谢旭明
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com